Skip to main content

Lyme Disease Continues to Move South into North Carolina: Boyce Encourages Healthcare Providers to Test Patients who Present with Typical Symptoms

June 10, 2024

Ross Boyce, MD, MSc, assistant professor of infectious diseases and epidemiologist with the UNC Institute for Global Health and Infectious Diseases, led a study published in Lancet Regional Health that examined the rapid emergence of Lyme Disease in N.C., between 2010 and 2020. Dr. Boyce says the results confirm what he has experienced clinically; specifically, an increasing … Read more

A New Partnership With UNC Project Malawi Will Focus On Cardiovascular Health

May 29, 2024

The Malawi Government has a strong commitment to caring for its citizens, often sending patients abroad, to countries such as India, for cardiac procedures that aren’t available at home. But these opportunities are limited, compared to the needs of the country’s population of 21 million, and follow a process much like a lottery. As a … Read more

OB-GYN Researchers Introduce Topical Therapy Advancements at American Society for Colposcopy and Cervical Pathology

May 27, 2024

Chemtai Mungo, MD, MPH, and Lisa Rahangdale, MD, MPH, presented at the American Society for Colposcopy and Cervical Pathology (ASCCP) meeting on May 4, focusing on the latest advancements in topical therapies for cervical precancer treatment in the U.S. and around the world. Dr. Mungo and Dr. Rahangdale, both obstetricians/gynecologists and clinical researchers, provided a … Read more

Supporting People Living With HIV In Vietnam

May 26, 2024

Clinical Trials Day honors all that has been accomplished through clinical trials, as well as the people behind them. The UNC Global Clinical Trials Unit at the Institute for Global Health and Infectious Diseases (IGHID) facilitates high-quality research, with investigators and research coordinators working to address the challenging questions that need answers, that impact the lives … Read more

Q&A: Investigators Discuss AMR Research at UNC’s Institute for Global Health and Infectious Diseases

May 16, 2024

Antimicrobial Resistant (AMR) research at the UNC Institute for Global Health and Infectious Diseases brings together collaborators from schools and departments across UNC. Following is an interview with David van Duin, MD, PhD, Brian Conlon, PhD, Luther Bartelt, MD, Tessa Andermann, MD, MPH, and Jonathan Juliano, MD, MSPH, DTM&H. Why is antimicrobial resistance an important issue? … Read more

Study Finds Increased Risk for Hospital-Acquired Bloodstream Infections Among Racial and Ethnic Minorities

May 16, 2024

A nationwide analysis of a large, geographically diverse cohort of adults in the U.S. suggests there is an increased risk for hospital-acquired carbapenem-resistant enterobacterales (CRE) bloodstream infections among racial and ethnic minorities. Felicia Ruffin, PhD, is a researcher at Duke University School of Medicine in the research group of Vance Fowler, MD, MHS. For this … Read more

Study Shows Drug Use-Associated Endocarditis Increases Hospital Risk For Bacterial Infections

May 10, 2024

David Rosen, PhD, MD, and Asher Schranz, MD, MPH, members of the Institute for Global Health and Infectious Diseases, found people with drug use-associated infective endocarditis are at high risk of mortality and future hospitalization for bacterial infections, including endocarditis, skin and soft tissue infections and bacteremia. The study, a collaboration with the North Carolina … Read more

Lemon Elected to the National Academy of Sciences

April 30, 2024

Stanley M. Lemon, MD, a member of the Institute for Global Health and Infectious Diseases and professor of medicine in infectious diseases and microbiology and immunology, has been elected to the National Academy of Sciences. Membership is a widely accepted mark of excellence in science and is considered one of the highest honors that a scientist … Read more

UNC Global Clinical Trials Unit Launches New HIV Drug Combination For Enhancing Immune Response and Suppression

April 30, 2024

The Institute for Global Health and Infectious Disease’s Global Clinical Trials Unit attracts leading trials from national feeder networks to study treatment innovations that can advance health. A new HIV study with the ACTG will evaluate the safety, tolerability, and antiviral effect of a novel combination regimen that includes therapeutic T-cell vaccines, two broadly neutralizing … Read more

The Continued Rise in Syphilis Cases: An Increasing Priority For Global Public Health

April 25, 2024

April is sexually transmitted infections (STI) awareness month, and Arlene Seña, MD, MPH, a researcher with the Institute for Global Health and Infectious Diseases, is sounding the alarm about the importance of syphilis prevention, testing, and treatment. U.S. syphilis cases have increased nearly 80% since 2018,  a level not seen since 1950, while babies born … Read more

UNC Research Features Joe Tucker in “Rooted” Profile

April 22, 2024

UNC Research recently featured Joe Tucker, MD, PhD, in a “Rooted” profile. He is a professor of medicine in the Department of Medicine’s Division of Infectious Diseases and director of UNC Project-China with the Institute for Global Health and Infectious Diseases. In this feature, Tucker explains how the pay-it-forward approach to infectious disease testing is a wonderful … Read more

The Lancet ID Publishes Tribute to Life of Adaora “Ada” Alise Adimora

April 2, 2024

The Lancet ID has published a tribute to Ada Adimora and her life, describing her as a “tireless and compassionate champion for the global HIV community.”  Myron Cohen, MD, director of the Institute for Global Health and Infectious Diseases, and Joe Eron, MD, chief of the division of infectious diseases were interviewed for the article. Read here. … Read more

Dr. Linda Van Le Presents at the Consortium of Universities for Global Health Conference

April 2, 2024

Linda Van Le, MD, the Leonard Palumbo Distinguished Professor in the Division of Gyn Oncology, served as moderator for the Consortium of Universities for Global Health’s Annual Conference in Los Angeles, March 7-10. Van Le gave two presentations, focused on elimination of cervical cancer as a public health problem and the need for cancer treatment worldwide. “Global Health Without … Read more

Long Covid Is Real: Researchers Seek Participants for NIH Study Trial During Long Covid Awareness Month

March 26, 2024

March is Long COVID Awareness Month, marking four years since COVID-19 was declared a pandemic. But while much of society has moved on from masking, quarantining, and isolating, there are many who are managing health problems long after having COVID-19.  Researchers at the Institute for Global Health and Infectious Diseases are participating in the NIH Phase 2 Recover-Vital trial to … Read more

UNC Researchers Lead HPV Research and Global Cancer Scientific Session at the EUROGIN International Multidisciplinary HPV Congress in Stockholm 

March 26, 2024

UNC researchers in cervical cancer prevention, members of the Institute for Global Health and Infectious Diseases and Lineberger Comprehensive Cancer Center, filled the agenda at a recent scientific session for the EUROGIN International Multidisciplinary HPV Conference in Stockholm, Sweden.       EUROGIN’s U.S. Chair Jennifer S. Smith, PhD, professor of epidemiology at the UNC Gillings … Read more

IAMIGHID: Amy James Loftis

March 25, 2024

In November 2020, Amy James Loftis was hyper-focused on keeping the Carolina community safe, building UNC’s COVID Surveillance Lab in three short months before the return of students. But there were many years leading up to that moment. Often described as the Institute’s secret weapon in the fight against global health disease, Amy travels around … Read more

Hepatitis B Elimination in sub-Saharan Africa: Peyton Thompson Leads Kinshasa-based Research Team Paving the Way For Virus-Free Generations

March 25, 2024

As the World Health Organization pushes to eradicate the Hepatitis B virus (HBV) by 2030, preventing vertical transmission is key, says Peyton Thompson, MD, MSCR, Assistant Professor of Pediatric Infectious Diseases. But despite widespread availability of effective childhood vaccines, HBV remains endemic throughout sub-Saharan Africa, including the Democratic Republic of the Congo (DRC). “Many of the … Read more